STAAR SURGICAL COMPANY (STAA)

STAAR Surgical reported first-quarter results that surpassed Wall Street's revenue forecasts, as the medical lens company continued to recover from earlier operational setbacks. According to the company's financial update, sales jumped 120% year over year to $93.52 million. Non-GAAP earnings came ..…

STAAR Surgical currently trades at $32.58, up from $29.40 just before the earnings. Is there an opportunity in the stock?Find out in our full research report (it’s free).

STAAR Surgical Co has moved back into the spotlight after delivering an earnings beat for the first quarter of 2026 and receiving a fresh analyst upgrade, while the share price has risen strongly since January. The manufacturer of implantable lenses for the eye reported Q1 2026 earnings per share of…

Shares of Staar Surgical (STAA) ... on the stock following strong quarterly results. Wedbush updated Staar Surgical to ‘Outperform’ from a ‘Neutral’ rating and hiked its price target to $40 from $26, representing a 53% hike from the firm's previous estimate. Wedbush stated that Staar Surgical’s firs…

Staar Surgical (STAA) delivered earnings and revenue surprises of +192.31% and +1.88%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?